Media & Events
Contact
Investors
About
+
-
Get To Know Us
Leadership Team
Board Of Directors
Commercial Team
A Welcoming CDMO: It's The Texas In Us
Careers
Clinical Biomanufacturing
+
-
Clinical Biomanufacturing
+
-
cGMP Mammalian Cell Culture
cGMP Microbial Fermentation
Process Development
+
-
Mammalian Cell Culture Development
Cell Therapy Development
Microbial Fermentation Development
Downstream Process Development
Formulation Development
Commercial Manufacturing
Bioanalytical Services
+
-
Methods Development
Technologies
Pre-Clinical & Product Development Services
+
-
Toxicokinetic Studies (TK)
Comprehensive Immune Profiling
Cell-Based Potency Assays
CMC Analytical Support Services
+
-
Release Testing
Stability Testing
Bioassays
Media & Events
Contact
Investors
News
All Media
News
Events
Articles
Blogs
Resources
NightHawk Biosciences Completes Name Change to Scorpius Holdings
NightHawk Biosciences announced its name change to Scorpius Holdings, Inc., to better reflect the company’s successful shift into a pure-play, large molecule biomanufacturing CDMO.
February 6, 2024
news
Scorpius BioManufacturing Announces Joe Payne as President and Chief Operating Officer
Scorpius BioManufacturing, a biologics contract development and manufacturing organization (CDMO), promoted Joe Payne to President and COO.
February 1, 2024
news
Fina Biosolutions Selects Scorpius BioManufacturing for Production of cGMP CRM₁₉₇
Fina Biosolutions has selected Scorpius BioManufacturing, a biologics contract development and manufacturing organization (CDMO), for the production of an E.coli-expressed CRM
197
conjugate ...
July 27, 2023
news
Scorpius Expands Leadership Team With New VP, Manufacturing Operations
Scorpius BioManufacturing, a biologics contract development and manufacturing organization (CDMO), expanded its leadership to include Matthew R. LeClair.
July 7, 2023